Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics ; volume:5 ; number:1 ; day:27 ; month:5 ; year:2005 ; pages:1-11 ; date:12.2005
BMC psychiatry ; 5, Heft 1 (27.5.2005), 1-11, 12.2005
- Urheber
-
Faries, Douglas
- Beteiligte Personen und Organisationen
-
Ascher-Svanum, Haya
Zhu, Baojin
Correll, Christoph
Kane, John
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-5-26
- URN
-
urn:nbn:de:1111-2016030423892
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Faries, Douglas
- Ascher-Svanum, Haya
- Zhu, Baojin
- Correll, Christoph
- Kane, John
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
Thyroid axis function after in-patient treatment of acute psychosis with antipsychotics: a naturalistic study
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
Thyroid axis function after in-patient treatment of acute psychosis with antipsychotics: a naturalistic study
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
Thyroid axis function after in-patient treatment of acute psychosis with antipsychotics: a naturalistic study